Site-specific clinical disease onset in multiple sclerosis

M. D. Willis, K. E. Harding, M. Wardle, T. P. Pickersgill, V. Tomassini, S. Loveless, N. P. Robertson

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background and purpose: Multiple sclerosis is a chronic inflammatory disorder of the central nervous system characterized by acute episodes of neurological dysfunction thought to reflect focal areas of demyelination occurring in clinically eloquent areas. These symptomatic relapses are generally considered to be random clinical events occurring without discernible pattern. The hypothesis that relapses may follow a predetermined sequence and may provide insights into underlying pathological processes was investigated. Methods: Employing prospective clinical database data from 1482 patients who had experienced one or more consecutive relapses were analysed. Using regression analysis, site and symptom of index event were compared with those of first relapse. Results: It is demonstrated that following disease ignition subsequent relapses may not be random events but dependent on characteristics of the index event. All anatomical sites were more likely to be affected in the first relapse if that site had been involved in the index event with a similar association observed when comparing by symptoms. Conclusion: These findings have importance in understanding the evolution of the disease and predicting individual disease progression and may aid with patient counselling and management.

Original languageEnglish
Pages (from-to)732-735
Number of pages4
JournalEuropean Journal of Neurology
Volume22
Issue number4
DOIs
Publication statusPublished - Apr 1 2015

Fingerprint

Multiple Sclerosis
Recurrence
Central Nervous System Diseases
Demyelinating Diseases
Pathologic Processes
Disease Progression
Counseling
Regression Analysis
Databases

Keywords

  • Multiple sclerosis
  • Relapse

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Medicine(all)

Cite this

Willis, M. D., Harding, K. E., Wardle, M., Pickersgill, T. P., Tomassini, V., Loveless, S., & Robertson, N. P. (2015). Site-specific clinical disease onset in multiple sclerosis. European Journal of Neurology, 22(4), 732-735. https://doi.org/10.1111/ene.12564

Site-specific clinical disease onset in multiple sclerosis. / Willis, M. D.; Harding, K. E.; Wardle, M.; Pickersgill, T. P.; Tomassini, V.; Loveless, S.; Robertson, N. P.

In: European Journal of Neurology, Vol. 22, No. 4, 01.04.2015, p. 732-735.

Research output: Contribution to journalArticle

Willis, MD, Harding, KE, Wardle, M, Pickersgill, TP, Tomassini, V, Loveless, S & Robertson, NP 2015, 'Site-specific clinical disease onset in multiple sclerosis', European Journal of Neurology, vol. 22, no. 4, pp. 732-735. https://doi.org/10.1111/ene.12564
Willis MD, Harding KE, Wardle M, Pickersgill TP, Tomassini V, Loveless S et al. Site-specific clinical disease onset in multiple sclerosis. European Journal of Neurology. 2015 Apr 1;22(4):732-735. https://doi.org/10.1111/ene.12564
Willis, M. D. ; Harding, K. E. ; Wardle, M. ; Pickersgill, T. P. ; Tomassini, V. ; Loveless, S. ; Robertson, N. P. / Site-specific clinical disease onset in multiple sclerosis. In: European Journal of Neurology. 2015 ; Vol. 22, No. 4. pp. 732-735.
@article{c303be6bddd34a3e80070f3e2db91509,
title = "Site-specific clinical disease onset in multiple sclerosis",
abstract = "Background and purpose: Multiple sclerosis is a chronic inflammatory disorder of the central nervous system characterized by acute episodes of neurological dysfunction thought to reflect focal areas of demyelination occurring in clinically eloquent areas. These symptomatic relapses are generally considered to be random clinical events occurring without discernible pattern. The hypothesis that relapses may follow a predetermined sequence and may provide insights into underlying pathological processes was investigated. Methods: Employing prospective clinical database data from 1482 patients who had experienced one or more consecutive relapses were analysed. Using regression analysis, site and symptom of index event were compared with those of first relapse. Results: It is demonstrated that following disease ignition subsequent relapses may not be random events but dependent on characteristics of the index event. All anatomical sites were more likely to be affected in the first relapse if that site had been involved in the index event with a similar association observed when comparing by symptoms. Conclusion: These findings have importance in understanding the evolution of the disease and predicting individual disease progression and may aid with patient counselling and management.",
keywords = "Multiple sclerosis, Relapse",
author = "Willis, {M. D.} and Harding, {K. E.} and M. Wardle and Pickersgill, {T. P.} and V. Tomassini and S. Loveless and Robertson, {N. P.}",
year = "2015",
month = "4",
day = "1",
doi = "10.1111/ene.12564",
language = "English",
volume = "22",
pages = "732--735",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "4",

}

TY - JOUR

T1 - Site-specific clinical disease onset in multiple sclerosis

AU - Willis, M. D.

AU - Harding, K. E.

AU - Wardle, M.

AU - Pickersgill, T. P.

AU - Tomassini, V.

AU - Loveless, S.

AU - Robertson, N. P.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Background and purpose: Multiple sclerosis is a chronic inflammatory disorder of the central nervous system characterized by acute episodes of neurological dysfunction thought to reflect focal areas of demyelination occurring in clinically eloquent areas. These symptomatic relapses are generally considered to be random clinical events occurring without discernible pattern. The hypothesis that relapses may follow a predetermined sequence and may provide insights into underlying pathological processes was investigated. Methods: Employing prospective clinical database data from 1482 patients who had experienced one or more consecutive relapses were analysed. Using regression analysis, site and symptom of index event were compared with those of first relapse. Results: It is demonstrated that following disease ignition subsequent relapses may not be random events but dependent on characteristics of the index event. All anatomical sites were more likely to be affected in the first relapse if that site had been involved in the index event with a similar association observed when comparing by symptoms. Conclusion: These findings have importance in understanding the evolution of the disease and predicting individual disease progression and may aid with patient counselling and management.

AB - Background and purpose: Multiple sclerosis is a chronic inflammatory disorder of the central nervous system characterized by acute episodes of neurological dysfunction thought to reflect focal areas of demyelination occurring in clinically eloquent areas. These symptomatic relapses are generally considered to be random clinical events occurring without discernible pattern. The hypothesis that relapses may follow a predetermined sequence and may provide insights into underlying pathological processes was investigated. Methods: Employing prospective clinical database data from 1482 patients who had experienced one or more consecutive relapses were analysed. Using regression analysis, site and symptom of index event were compared with those of first relapse. Results: It is demonstrated that following disease ignition subsequent relapses may not be random events but dependent on characteristics of the index event. All anatomical sites were more likely to be affected in the first relapse if that site had been involved in the index event with a similar association observed when comparing by symptoms. Conclusion: These findings have importance in understanding the evolution of the disease and predicting individual disease progression and may aid with patient counselling and management.

KW - Multiple sclerosis

KW - Relapse

UR - http://www.scopus.com/inward/record.url?scp=84924517962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924517962&partnerID=8YFLogxK

U2 - 10.1111/ene.12564

DO - 10.1111/ene.12564

M3 - Article

C2 - 25196326

AN - SCOPUS:84924517962

VL - 22

SP - 732

EP - 735

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 4

ER -